Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |